Regulation

Cerebral Inc. to Stop Prescribing Most Controlled Substances by Fall Amid Telehealth Controlled Substance Prescribing Changes

Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....

Talkspace Partners with Evernow to Elevate Menopause Mental Health Support for Women

In recent years, the importance of mental health has gained significant attention, and now more companies are recognizing...

Telehealth Usage Surges in Behavioral Health, Especially Among Commercially-Insured Patients

The adoption of telehealth for behavioral health services has accelerated dramatically over the past few years, with commercially-insured...

The Growing Rural Opioid Crisis: Challenges and Opportunities for Treatment

Opioid addiction has become a significant issue in the United States, with the rural opioid crisis hitting communities...

Concert Health Secures $42 Million Series B to Expand Collaborative Behavioral Health Care

Concert Health, a technology-driven behavioral health medical group, recently closed a $42 million Series B funding round. The...
spot_img

$312 Million in Federal Funding for Mental Health and Substance Use Treatment to Expand Access Across the U.S.

The behavioral health system in the United States is receiving a critical injection of support, as the U.S. Department of Health and Human Services...

Medicaid Funding Clawbacks in Behavioral Health Highlight Ongoing Fraud Challenges

The behavioral health sector experienced significant Medicaid funding clawbacks in federal fiscal year 2021, as revealed in a recent report from the Office of...

Bringing Medication-Assisted Treatment to the Forefront of the Nation’s Addiction Crisis

The United States is grappling with a worsening addiction and overdose epidemic—one that has claimed more than 105,000 lives in a recent 12-month period—highlighting...

The Growing Crisis in Intellectual and Developmental Disabilities (I/DD) Services: Reimbursement and Workforce Challenges Demand Urgent Action

Intellectual and developmental disabilities (I/DD) services have long faced significant challenges, particularly regarding reimbursement and workforce stability. A recent report released jointly by the...

$25.6M Federal Investment Expands Medication-Assisted Treatment for Opioid Use Disorder and Prevents Prescription Drug Misuse

In a pivotal move to tackle America’s overdose epidemic, the U.S. Department of Health and Human Services (HHS) has announced $25.6 million in federal...

Contingency Management: A Game-Changer in Treating Substance Use Disorders

Substance use disorders (SUDs) continue to present significant challenges across the healthcare landscape. Traditional treatment methods, while helpful for many, have not always succeeded...
spot_img